New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results also showcase the successful design of a proprietary pre ...
50m
Servier today announced that it will present data at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback